1. Phosphatidylinositol-3-Kinase Mutations Are Associated With Increased Local Failure in Brain Metastases Treated With Radiation.
- Author
-
Lockney, Natalie A., Wang, Diana G., Pei, Xin, Goldman, Debra A., Zhang, Zhigang, Lin, Andrew, Chan, Timothy A., Yamada, Yoshiya, Beal, Kathryn, and Yang, T. Jonathan
- Subjects
- *
PHOSPHATIDYLINOSITOL 3-kinases , *BRAIN metastasis , *CANCER radiotherapy , *GENETIC mutation , *CANCER genetics , *THERAPEUTICS , *ANALYSIS of variance , *BRAIN tumors , *CONFIDENCE intervals , *PHOSPHOTRANSFERASES , *RADIOSURGERY , *RADIOTHERAPY , *TREATMENT effectiveness , *RETROSPECTIVE studies - Abstract
Purpose: To determine whether phosphatidylinositol-3-kinase (PI3K) mutations confer suboptimal local control after radiation therapy (RT) for brain metastases.Methods and Materials: We retrospectively reviewed 259 patients with brain metastases treated with RT during the period 2004 to 2017 for whom tumor genetic data (MSK-IMPACT) were available for primary or metastatic lesions. Associations between clinical factors, PI3K mutations status, and local failure (LF) were evaluated with univariate and multivariate competing risks regression.Results: A total of 112 patients received whole brain radiation therapy (WBRT) to a median dose of 30 Gy in 10 fractions, and 147 patients received stereotactic radiosurgery (SRS) to 338 lesions; 276 lesions were treated with single fraction SRS (median dose 21 Gy) and 76 lesions over 3 to 5 fractions SRS (median dose 30 Gy). PI3K mutations were present in 36 WBRT patients (32%) and 44 SRS patients (30%). For WBRT, patients with PI3K mutations (hazard ratio 2.67, P < .001) were found to be at higher risk for LF on multivariable analysis, and the 1-year cumulative incidence of LF was 50% (95% confidence interval [CI] 32%-65%) for patients with PI3K mutations versus 26% (95% CI 17%-37%) for patients without PI3K mutations. For SRS lesions, while PI3K mutations positivity was not statistically significantly associated with LF, higher rate of LF was observed: 1-year LF cumulative incidence of 11% (95% CI 6%-17%) for patients with PI3K mutations versus 5% (95% CI 3%-9%) for patients without PI3K mutations.Conclusion: Patients with PI3K mutations are at higher risk for LF for brain metastases after RT. Novel therapeutic strategies to improve treatment outcomes in these patients should be considered. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF